Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3.

Ahmed M, Cheng M, Zhao Q, Goldgur Y, Cheal SM, Guo HF, Larson SM, Cheung NK.

J Biol Chem. 2015 Dec 11;290(50):30018-29. doi: 10.1074/jbc.M115.679852. Epub 2015 Oct 20.

2.

Radioimmunotherapy of human tumours.

Larson SM, Carrasquillo JA, Cheung NK, Press OW.

Nat Rev Cancer. 2015 Jun;15(6):347-60. doi: 10.1038/nrc3925. Review. Erratum in: Nat Rev Cancer. 2015 Aug;15(8):509.

3.

Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy.

Kramer K, Pandit-Taskar N, Zanzonico P, Wolden SL, Humm JL, DeSelm C, Souweidane MM, Lewis JS, Cheung NK.

J Neurooncol. 2015 Jun;123(2):245-9. doi: 10.1007/s11060-015-1788-z. Epub 2015 May 6.

4.

Medulloblastoma development: tumor biology informs treatment decisions.

Gopalakrishnan V, Tao RH, Dobson T, Brugmann W, Khatua S.

CNS Oncol. 2015;4(2):79-89. doi: 10.2217/cns.14.58. Review.

5.

GD2-targeted immunotherapy and radioimmunotherapy.

Dobrenkov K, Cheung NK.

Semin Oncol. 2014 Oct;41(5):589-612. doi: 10.1053/j.seminoncol.2014.07.003. Epub 2014 Jul 21. Review.

6.

Quantification of transient increase of the blood-brain barrier permeability to macromolecules by optimized focused ultrasound combined with microbubbles.

Shi L, Palacio-Mancheno P, Badami J, Shin DW, Zeng M, Cardoso L, Tu R, Fu BM.

Int J Nanomedicine. 2014 Sep 18;9:4437-48. doi: 10.2147/IJN.S68882. eCollection 2014.

7.

Immunotherapy in pediatric malignancies: current status and future perspectives.

Capitini CM, Otto M, DeSantes KB, Sondel PM.

Future Oncol. 2014;10(9):1659-78. doi: 10.2217/fon.14.62. Review.

8.

Cytotoxic Effect of Immunotoxin Containing The Truncated Form of Pseudomonas Exotoxin A and Anti-VEGFR2 on HUVEC and MCF-7 Cell Lines.

Safari E, Zavaran Hosseini A, Hassan Z, Khajeh K, Ardestani MS, Baradaran B.

Cell J. 2014 Summer;16(2):203-10. Epub 2014 May 25.

9.

Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment.

Leal T, Chang JE, Mehta M, Robins HI.

Curr Cancer Ther Rev. 2011 Nov;7(4):319-327.

10.

Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment.

van Maldegem AM, Bhosale A, Gelderblom HJ, Hogendoorn PC, Hassan AB.

Clin Sarcoma Res. 2012 Jan 27;2(1):5. doi: 10.1186/2045-3329-2-5.

11.

Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy.

Durrant LG, Noble P, Spendlove I.

Clin Exp Immunol. 2012 Feb;167(2):206-15. doi: 10.1111/j.1365-2249.2011.04516.x. Review.

12.

Cancer radioimmunotherapy.

Sharkey RM, Goldenberg DM.

Immunotherapy. 2011 Mar;3(3):349-70. doi: 10.2217/imt.10.114. Review.

13.

[Lu]-DOTA-Tyr-octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma.

Vaidyanathan G, Affleck DJ, Zhao XG, Keir ST, Zalutsky MR.

Curr Radiopharm. 2010;3(1):29-36.

14.

Radioimmunotherapy of solid tumors: searching for the right target.

Song H, Sgouros G.

Curr Drug Deliv. 2011 Jan;8(1):26-44. Review.

15.

Two-compartment model of radioimmunotherapy delivered through cerebrospinal fluid.

He P, Kramer K, Smith-Jones P, Zanzonico P, Humm J, Larson SM, Cheung NK.

Eur J Nucl Med Mol Imaging. 2011 Feb;38(2):334-42. doi: 10.1007/s00259-010-1633-8. Epub 2010 Oct 9. Erratum in: Eur J Nucl Med Mol Imaging. 2011 Feb;38(2):410.

16.

Anti-GD2 antibody therapy for GD2-expressing tumors.

Navid F, Santana VM, Barfield RC.

Curr Cancer Drug Targets. 2010 Mar;10(2):200-9. Review.

17.

High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma.

Dunkel IJ, Gardner SL, Garvin JH Jr, Goldman S, Shi W, Finlay JL.

Neuro Oncol. 2010 Mar;12(3):297-303. doi: 10.1093/neuonc/nop031. Epub 2010 Jan 11.

18.

Immunotherapy of childhood cancer: from biologic understanding to clinical application.

Wayne AS, Capitini CM, Mackall CL.

Curr Opin Pediatr. 2010 Feb;22(1):2-11. doi: 10.1097/MOP.0b013e3283350d3e. Review.

19.

Immune-based therapeutics for pediatric cancer.

Capitini CM, Mackall CL, Wayne AS.

Expert Opin Biol Ther. 2010 Feb;10(2):163-78. doi: 10.1517/14712590903431022. Review.

20.

Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma.

Kramer K, Kushner BH, Modak S, Pandit-Taskar N, Smith-Jones P, Zanzonico P, Humm JL, Xu H, Wolden SL, Souweidane MM, Larson SM, Cheung NK.

J Neurooncol. 2010 May;97(3):409-18. doi: 10.1007/s11060-009-0038-7. Epub 2009 Nov 5.

Supplemental Content

Support Center